INDIGO Press Releases

Catch up on the latest news and announcements from INDIGO Biosciences.

INDIGO Biosciences Introduces Cell-Based Luciferase Reporter Assay for the Human c-Met / Hepatocyte Growth Factor Receptor

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Sensitive, Time-Saving Assay for Preclinical Research of Cancer, Fibrosis, and Inflammatory Diseases State College, PA (21 May 2024) – INDIGO Biosciences, a leading developer of innovative cell-based reporter assays, announced today the launch of its latest assay: the Human c-MET / Hepatocyte Growth Factor…

INDIGO Biosciences Introduces Cell-Based Luciferase Reporter Assay for Hepatocyte Nuclear Factor 4 Alpha (HNF4α)

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Sensitive, Time-Saving Assay for Preclinical Research of Metabolic Regulation and Disease Pathogenesis. State College, PA (20 April 2024) – INDIGO Biosciences, a leading provider of innovative cell-based reporter assays, announced today the launch of its latest Nuclear Receptor Assay: the Human Hepatocyte Nuclear Factor…

INDIGO Biosciences Releases Cell-Based Luciferase Reporter Assay for the Human Oxytocin Receptor

INDIGO’s New Assay for Preclinical Research of Cancer and Autoimmune Diseases GM-CSFR. State College, PA (20 March 2024) – INDIGO Biosciences, a leading provider of innovative cell-based reporter assays, announced today the launch of its latest G-Protein Coupled Receptor assay: the Human Oxytocin Receptor (OXTR) Reporter Assay. “INDIGO is pleased to introduce this robust assay,”…

INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Adrenergic Receptors

A New Family of Assays Including ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 for Preclinical Research of Heart Failure, Hypertension, Obesity, and Respiratory Conditions State College, PA (February 21th, 2024) – INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Adrenergic Receptors, including ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2. “INDIGO is…

INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Colony Stimulating Factor Receptors G-CSFR, M-CSFR, & GM-CSFR

A New Family of Assays for Preclinical Research of Cancer, Inflammation & Autoimmune Disorders State College, PA (17 January 2024) – INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Colony-Stimulating Factor Receptors: Granulocyte Colony-Stimulating Factor Receptor (G-CSFR), Macrophage Colony-Stimulating Factor Receptor (M-CSFR), and Granulocyte Macrophage Colony-Stimulating Factor…

INDIGO Biosciences Wraps Up 2023 with a Record Number of New Product Releases

New Cell-Based Reporter Assays Included Those for Nuclear Receptors, GPCRs, and Growth Factors State College, PA (January 12th, 2024) – INDIGO Biosciences concluded 2023 with a record number of new product releases, adding 17 new assays to its portfolio of cell-based reporter gene assays targeting Nuclear Receptors, G-protein Coupled Receptors (CPCRs), Growth Factors, Transcription Factors,…

INDIGO Biosciences Releases Cell-Based Luciferase Reporter Assay for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R)

A New Assay for Preclinical Research of Type II Diabetes and Obesity State College, PA (20 November 2023) – INDIGO Biosciences announced today the release of a new cell-based reporter assay for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R), a member of the G protein-coupled receptor (GPCR) family. “A reliable GLP-1R assay is essential for researchers…

INDIGO Biosciences Releases Cell-Based Luciferase Assay for the Human Adrenoreceptor Alpha 1A (ADRA1A)

A New Assay for Preclinical Research of Neurological Disease, Cardiovascular Disease, and Diabetes. State College, PA  – September 25th, 2023 INDIGO Biosciences announced today the release of a new cell-based reporter assay for the Human Adrenoreceptor Alpha 1A (ADRA1A), a member of the G protein-coupled receptor (GPCR) family. “Since ADRA1A has the potential to be…

New Assay Cell-Based Luciferase Reporter Assay developed for GM-CSFR

INDIGO’s New Assay for Preclinical Research of Cancer and Autoimmune Diseases GM-CSFR. State College, PA (June 27th, 2023) – Today INDIGO Biosciences announced the release of a new cell-based reporter assay for Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR or CSF2R). This new commercially available all-inclusive assay kit from INDIGO can help preclinical researchers get the data…

New Environmental Monitoring and Toxicology Assays

INDIGO’s New Family of Assays for Environmental Monitoring and Toxicology Provide a Screening Tool for Endocrine Disrupting Chemicals. State College, PA (May 18, 2023) – Today INDIGO Biosciences released a new family of cell-based luciferase reporter assays specifically developed for use in environmental testing applications such as screening samples for endocrine disrupting chemicals. The assays…